Double venipuncture is not required for adequate S-100B determination in melanoma patients

Autor: Samantha Damude, Anneke C Muller Kobold, Esther Bastiaannet, Schelto Kruijff, Harald J Hoekstra, Kevin P Wevers

Publikováno v: BioTechniques, Vol 69, Iss 5, Pp 371-378 (2020)

S-100B is used in melanoma follow-up. This serum biomarker is also present in adipocytes; therefore, subcutaneous adipocytes trapped in the needle before performing a venipuncture could contaminate the serum. The aim was to study the influence of adi

Externí odkaz: https://doaj.org/article/204c0200743940ffbfcd777951a5c650

18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC)

Autor: Miriam P. van der Meulen, Emma C. Gertsen, Jessy Joy van Kleef, Grard A. P. Nieuwenhuijzen, Edith Bouwmeester, Annemieke Y. Thijssen, Mariska Prins, Marc J. van Det, F. Daams, Nicole C.T. van Grieken, Boudewijn van Etten, Mark I. van Berge Henegouwen, Ernst J. Spillenaar Bilgen, Nadia Haj Mohammad, Jan H. M. B. Stoot, Jan W.K. van den Berg, Eelco Wassenaar, Monique Heijmans, Ilse Masselink, Lieke Hol, Kees de Mooij, Antoinette van Groenestyn, Jean Pierre Pierie, Peter van Duijvendijk, Misha D. P. Luyer, Stan Tummers, Richard van Hillegersberg, Kevin P. Wevers, Peter D. Siersema, Jerôme Profar, J. Jan B. van Lanschot, Ewout A. Kouwenhoven, Joyce Pijpers, Eric J. Th. Belt, Geert W.J. Frederix, Nel de Vries, Hanneke W. M. van Laarhoven, Sjoerd M. Lagarde, E. Vegt, Hasan H. Eker, Donald L. van der Peet, Jelle P. Ruurda, Hylke J. F. Brenkman, Wobbe O. de Steur, Bas P. L. Wijnhoven, Johanna W. van Sandick, Damiana Beumer, Henk H. Hartgrink, Suzanne S. Gisbertz, Frank J. Wessels, Karel W. E. Hulsewe, Maaike van Dam, Joos Heisterkamp

Publikováno v: JAMA Surgery, 156
JAMA Surgery, 156(12):e215340, E1-E9. American Medical Association
JAMA surgery, 156(12), E1-E9. American Medical Association
JAMA Surgery, 156(12), E1-E9. American Medical Association
JAMA Surgery, 156, 12
JAMA Surg
JAMA Surgery, 156(12), E1-E9. AMER MEDICAL ASSOC
Gertsen, E C, Brenkman, H J F, van Hillegersberg, R, van Sandick, J W, van Berge Henegouwen, M I, Gisbertz, S S, Luyer, M D P, Nieuwenhuijzen, G A P, van Lanschot, J J B, Lagarde, S M, Wijnhoven, B P L, de Steur, W O, Hartgrink, H H, Stoot, J H M B, Hulsewe, K W E, Spillenaar Bilgen, E J, van Det, M J, Kouwenhoven, E A, van der Peet, D L, Daams, F, van Grieken, N C T, Heisterkamp, J, van Etten, B, van den Berg, J W, Pierie, J P, Eker, H H, Thijssen, A Y, Belt, E J T, van Duijvendijk, P, Wassenaar, E, van Laarhoven, H W M, Wevers, K P, Hol, L, Wessels, F J, Haj Mohammad, N, van der Meulen, M P, Frederix, G W J, Vegt, E, Siersema, P D & Ruurda, J P 2021, ' 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer : A Multicenter Prospective Dutch Cohort Study (PLASTIC) ', JAMA Surgery, vol. 156, no. 12, pp. E1-E9 . https://doi.org/10.1001/jamasurg.2021.5340

Importance: The optimal staging for gastric cancer remains a matter of debate. Objective: To evaluate the value of 18F-fludeoxyglucose-positron emission tomography with computed tomography (FDG-PET/CT) and staging laparoscopy (SL) in addition to init

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f211ab0d584af50aaf7484606983698
https://doi.org/10.1001/jamasurg.2021.5340